Path Traversal Vulnerability in ZKTeco BioTime Product
CVE-2023-38950

7.5HIGH

Key Information:

Vendor

Zkteco

Status
Biotime
Vendor
CVE Published:
3 August 2023

Badges

👾 Exploit Exists🟣 EPSS 79%🦅 CISA Reported

What is CVE-2023-38950?

A path traversal vulnerability exists in the iclock API component of ZKTeco's BioTime product version 8.5.5. This flaw allows unauthenticated attackers to exploit the API by supplying crafted payloads, leading to unauthorized reading of arbitrary files on the server. Such vulnerabilities can expose sensitive data and pose significant security risks, particularly in enterprise environments.

CISA has reported CVE-2023-38950

CISA provides regional cyber and physical services to support security and resilience across the United States. CISA monitor the most dangerious vulnerabilities and have identifed CVE-2023-38950 as being exploited but is not known by the CISA to be used in ransomware campaigns. This is subject to change at pace

The CISA's recommendation is: Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.

References

http://zkteco.com
https://claroty.com/team82/disclosure-dashboard/cve-2023-...

EPSS Score

79% chance of being exploited in the next 30 days.

CVSS V3.1

Score:
7.5
Severity:
HIGH
Confidentiality:
High
Integrity:
None
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • 👾

    Exploit known to exist

  • 🦅

    CISA Reported

  • Vulnerability published

  • Vulnerability Reserved

.
CVE-2023-38950 : Path Traversal Vulnerability in ZKTeco BioTime Product